Combining NAD+ With Mounjaro — How They Work Together

Last reviewed: July 15, 2026

Last updated: July 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide activates two hormone receptors—GLP-1 and GIP—to reduce appetite and improve insulin sensitivity, while NAD+ supports cellular energy production and mitochondrial function. When used together under medical supervision, these interventions may create complementary metabolic effects that neither achieves alone. Understanding their mechanisms helps patients and providers decide if combination therapy aligns with individual health goals.

How Tirzepatide and NAD+ Work on Different Metabolic Pathways

Tirzepatide works by mimicking glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)—two hormones that regulate blood sugar, satiety, and fat storage. In clinical trials, tirzepatide produced weight loss of 20–22% over 68 weeks in people with obesity. NAD+ (nicotinamide adenine dinucleotide) is a coenzyme essential for energy metabolism, DNA repair, and sirtuin activation. These are distinct but potentially synergistic mechanisms: tirzepatide addresses appetite and insulin signaling, while NAD+ supports the cellular machinery that processes energy.

The dual-receptor action of tirzepatide slows gastric emptying, increases feelings of fullness, and improves how cells respond to insulin. Meanwhile, NAD+ fuels mitochondrial function through pathways like oxidative phosphorylation and activates sirtuins, proteins linked to longevity and metabolic health. A patient taking both compounds may experience enhanced fat oxidation and improved energy utilization during the weight loss process. This separation of effects—hormonal signaling plus cellular energy optimization—forms the theoretical basis for combination therapy.

Clinical Evidence for NAD+ and GLP-1 Receptor Agonist Combinations

Most research on NAD+ and weight loss has focused on NAD+ precursors (nicotinamide riboside and NMN) in animal models and small human studies. A 2021 study published in *Cell Metabolism* showed that increasing NAD+ in mice improved insulin sensitivity and reduced adipose tissue inflammation. While direct clinical trials combining NAD+ with GLP-1 agonists remain limited, emerging evidence suggests that NAD+ supplementation may support the metabolic improvements driven by tirzepatide—particularly in mitochondrial efficiency and glucose handling.

The rationale for combining them lies in their non-overlapping targets. Tirzepatide reduces caloric intake and improves glucose metabolism through hormone signaling; NAD+ enhances the capacity of cells to oxidize fat and maintain energy balance at lower body weights. Some functional medicine providers recommend NAD+ as an adjunct during intensive weight loss to sustain energy levels and support metabolic adaptation. However, more controlled trials are needed to establish optimal dosing, timing, and patient populations most likely to benefit.

Genetic Factors That May Influence NAD+ and Tirzepatide Response

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

A patient with a less responsive GLP1R variant may benefit more from NAD+ supplementation to enhance cellular energy and fat oxidation as a compensatory mechanism. Conversely, those with robust GLP1R and GIP signaling may achieve strong results from tirzepatide alone. Genetic testing allows providers to tailor combination therapy at the outset rather than using a one-size-fits-all approach. PlexusDx Precision Peptide testing is available for $99 as an add-on after the first month of treatment, enabling data-driven adjustments to support individual success.

Safety, Side Effects, and When to Combine NAD+ With Tirzepatide

Tirzepatide's most common side effects are gastrointestinal—nausea, vomiting, constipation, and diarrhea—which typically improve as the body adjusts. NAD+ supplements (nicotinamide riboside, NMN, or niacin precursors) are generally well-tolerated but may cause flushing, headaches, or mild GI upset in some users. Combining them poses no known direct pharmacological interaction, but timing and dosing should be coordinated with a healthcare provider. Taking NAD+ precursors in the evening or spacing them from tirzepatide injections may reduce overlap of GI effects.

Patients already managing nausea from tirzepatide should discuss NAD+ supplementation with their provider before starting. Certain NAD+ forms (like niacin) can affect cholesterol and blood sugar levels, so baseline labs and monitoring are wise. Pregnant or breastfeeding individuals should avoid both compounds. PlexusDx providers review full medical histories and current supplements when prescribing tirzepatide, ensuring safe integration of any complementary therapies a patient considers. Open communication about the goal of combining approaches helps optimize tolerability and outcomes.

Getting Started With Tirzepatide at PlexusDx

PlexusDx offers Compounded Tirzepatide Injection at $289/mo month-to-month, or from $249/mo on the 6-month plan, supplied by licensed 503A compounding pharmacies. The flat-monthly pricing model means your dose may need to go up as you progress through treatment, but your price won't—keeping costs predictable and transparent. PlexusDx serves all 50 states without requiring insurance, membership fees, or prior authorization. Prescriptions are HSA/FSA eligible, and patients can begin therapy within days of a brief telehealth consultation.

For those interested in precision dosing informed by genetics, the Precision Peptide Genetic Test ($99 add-on after month one) reveals individual variations in GLP1R, GIPR, FTO, MC4R, and other pathways tied to tirzepatide response and metabolic capacity. This genetic insight can guide decisions about supplementary NAD+ therapy or other adjuncts tailored to your genetic profile. If you're considering NAD+ and tirzepatide together, discuss both with your PlexusDx provider during your initial consultation to ensure safety and alignment with your personalized treatment plan.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Will adding NAD+ to tirzepatide make me lose weight faster?

NAD+ may enhance cellular energy and fat oxidation, potentially supporting weight loss outcomes when combined with tirzepatide. However, tirzepatide is the primary driver of appetite suppression and metabolic improvement. Any benefit from NAD+ likely complements rather than multiplies weight loss; clinical data directly comparing tirzepatide alone versus tirzepatide plus NAD+ is currently limited.

What does the research show about NAD+ and tirzepatide together?

Most evidence on NAD+ comes from animal studies and small human trials examining NAD+ metabolism and mitochondrial health. Direct clinical trials combining NAD+ with tirzepatide or other GLP-1 agonists have not been published in large-scale studies. Emerging functional medicine literature suggests the combination may be safe, but more controlled research is needed to establish efficacy and optimal dosing protocols.

How much does tirzepatide cost at PlexusDx, and can I add NAD+ supplementation?

Compounded Tirzepatide Injection at PlexusDx is $289/mo month-to-month (or $249/mo on the 6-month plan)—a flat rate regardless of dose strength. NAD+ supplements are purchased separately outside of PlexusDx prescriptions; your provider can recommend reputable brands and dosing. PlexusDx handles the tirzepatide; you'd source NAD+ products through other retailers or clinics specializing in performance or longevity medicine.

Are there any safety concerns mixing NAD+ with tirzepatide?

No direct drug interaction exists between NAD+ and tirzepatide. Both can cause mild gastrointestinal effects, so timing supplementation to minimize overlapping nausea is wise. Always inform your PlexusDx provider of any supplements you take, especially if you're already experiencing nausea from tirzepatide dose escalation, before starting NAD+ products.

Can the Precision Peptide Genetic Test help determine if NAD+ is right for me?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Hers Mounjaro
• Hims Mounjaro
• Mounjaro For Hypertension
• Mounjaro For Endometriosis

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.